Oncologia

Screening for Prostate Cancer - The Controversy That Refuses to Die

In the United States, most men over the age of 50 years have had a prostate-specific-antigen (PSA) test,1 despite the absence of evidence from large, randomized trials of a net benefit.
Approfondisci

 http://content.nejm.org/cgi/content/short/360/13/1351?rss=1&...

New England Journal of Medicine